Coexpression of VEGF and angiopoietin-1 promotes angiogenesis and cardiomyocyte proliferation reduces apoptosis in porcine myocardial infarction (MI) heart
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
VEGF and angiopoietin-1 (Ang1) are two major angiogenic factors being investigated for the treatment of myocardial infarction (MI). Targeting VEGF and Ang1 expression in the ischemic myocardium can increase their local therapeutic effects and reduce possible adverse effects. Adeno-associated viral vectors (AAVs) expressing cardiac-specific and hypoxia-inducible VEGF [AAV-myosin light chain-2v (MLC)VEGF] and Ang1 (AAV-MLCAng1) were coinjected (VEGF/Ang1 group) into six different sites of the porcine myocardium at the peri-infarct zone immediately after ligating the left descending coronary artery. An identical dose of AAV-Cytomegalovirus (CMV)LacZ or saline was injected into control animals. AAV genomes were detected in the liver in addition to the heart. RT-PCR, Western blotting, and ELISA analyses showed that VEGF and Ang1 were predominantly expressed in the myocardium in the infarct core and border of the infarct heart. Gated single-photon emission computed tomography analyses showed that the VEGF/Ang1 group had better cardiac function and myocardial perfusion at 8 wk than at 2 wk after vector injection. Compared with the saline and LacZ controls, the VEGF/Ang1 group expressed higher phosphorylated Akt and Bcl-xL, less Caspase-3 and Bad, and had higher vascular density, more proliferating cardiomyocytes, and less apoptotic cells in the infarct and peri-infarct zones. Thus, cardiac-specific and hypoxia-induced coexpression of VEGF and Ang1 improves the perfusion and function of porcine MI heart through the induction of angiogenesis and cardiomyocyte proliferation, activation of prosurvival pathways, and reduction of cell apoptosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging:, Cerqueira, M. D., Weissman, N. J., Dilsizian, V., Jacobs, A. K., Kaul, S., Laskey, W. K., Pennell, D. J., Rumberger, J. A., Ryan, T., et al. (2002) · Circulation · doi:10.1161/hc0402.102975 · Cited by 6,990
ACC/AHA/ASNC Guidelines for the Clinical Use of Cardiac Radionuclide Imaging—Executive Summary
Klocke, F. J., Baird, M. G., Lorell, B. H., Bateman, T. M., Messer, J. V., Berman, D. S., O’Gara, P. T., Carabello, B. A., Russell, R. O., Cerqueira, M. D., et al. (2003) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.08.011 · Cited by 1,303 · cited 1×
“Increase of LVEF and reduction of LVESV indicate improvement of cardiac function (29).”
BackgroundLosordo, D. W., Vale, P. R., Symes, J. F., Dunnington, C. H., Esakof, D. D., Maysky, M., Ashare, A. B., Lathi, K., & Isner, J. M. (1998) · Circulation · doi:10.1161/01.cir.98.25.2800 · Cited by 987
Gill, M., Dias, S., Hattori, K., Rivera, M. L., Hicklin, D., Witte, L., Girardi, L., Yurt, R., Himel, H., & Rafii, S. (2001) · Circulation Research · doi:10.1161/01.res.88.2.167 · Cited by 798 · cited 2×
“Discussion About 6–12% of symptomatic patients with extensive coronary artery disease are not amenable to conventional treatment, such as percutaneous transluminal coronary angioplasty (PTCA) or coronary artery bypass grafting (CABG) (22).”
BackgroundVEGF Gene Delivery to Myocardium: Deleterious Effects of Unregulated Expression
Lee, R. J., Springer, M. L., Blanco-Bose, W. E., Shaw, R., Ursell, P. C., & Blau, H. M. (2000) · Circulation · doi:10.1161/01.cir.102.8.898 · Cited by 697 · cited 1×
“It has been reported that unregulated and continuous expression of VEGF can lead to angioma formation at the site of injection (24, 25).”
BackgroundMyocyte proliferation in end-stage cardiac failure in humans
Kajstura, J., Leri, A., Finato, N., Di Loreto, C., Beltrami, C. A., & Anversa, P. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8801 · Cited by 567 · cited 1×
“The notions that mammalian cardiomyocytes irreversibly withdraw from the cell cycle soon after birth and that the mammalian heart is a terminally differentiated organ with no intrinsic capacity to regenerate after myocardial injury have been seriously challenged in recent years (16).”
BackgroundSchumacher, B., Pecher, P., von Specht, B. U., & Stegmann, T. (1998) · Circulation · doi:10.1161/01.cir.97.7.645 · Cited by 531
A cascade model for restenosis. A special case of atherosclerosis progression.
Libby, P., Schwartz, D., Brogi, E., Tanaka, H., & Clinton, S. K. (1992) · PubMed · Cited by 509
Adeno-associated virus vectors can be efficiently produced without helper virus
Matsushita, T., Elliger, S., Elliger, C., Podsakoff, G., Villarreal, L., Kurtzman, G., Iwaki, Y., & Colosi, P. (1998) · Gene Therapy · doi:10.1038/sj.gt.3300680 · Cited by 500 · cited 1×
“AAV vectors were packaged in AAV serotype one capsid and prepared by the three plasmid cotransfection system (33).”
MethodGiordano, F. J., Ping, P., McKirnan, M. D., Nozaki, S., Demaria, A. N., Dillmann, W. H., Mathieu-Costello, O., & Hammond, H. K. (1996) · Nature Medicine · doi:10.1038/nm0596-534 · Cited by 486
Cited by
Paul, A., Hasan, A., Kindi, H. A., Gaharwar, A. K., Rao, V. T. S., Nikkhah, M., Shin, S. R., Krafft, D., Dokmeci, M. R., Shum-Tim, D., et al. (2014) · ACS Nano · doi:10.1021/nn5020787 · Cited by 535
Oka, T., Akazawa, H., Naito, A. T., & Komuro, I. (2014) · Circulation Research · doi:10.1161/circresaha.114.300507 · Cited by 460
Korpela, H., Lampela, J., Airaksinen, J., Järveläinen, N., Siimes, S., Valli, K., Nieminen, T., Turunen, M., Grönman, M., Saraste, A., et al. (2022) · Gene Therapy · doi:10.1038/s41434-022-00322-9 · Cited by 22
“Previously it has been shown that AAV1 and AAV9 can successfully transduce pig myocardium [32 – 34].”
BackgroundChaar, D., Dumont, B. L., Vulesevic, B., Neagoe, P.-E., Räkel, A., White, M., & Sirois, M. G. (2022) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2022.05.026 · Cited by 22
Metadata
- Authors
- Tao, Z., Chen, B., Tan, X., Zhao, Y., Wang, L., Zhu, T., Cao, K., Yang, Z., Kan, Y. W., & Su, H.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2011-01-18
- Volume
- 108
- Issue
- 5
- Pages
- 2064-2069
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2103657052
- Cited by
- 177
- References
- 34
- FWCI
- 6.35
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Coexpression of VEGF and angiopoietin-1 promotes angiogenesis and cardiomyocyte proliferation reduces apoptosis in porcine myocardial infarction (MI) heart. https://app.cochat.ai/papers/10.1073/pnas.1018925108
- The paper
- Tao, Z., Chen, B., Tan, X., Zhao, Y., Wang, L., Zhu, T., Cao, K., Yang, Z., Kan, Y. W., & Su, H. (2011). Coexpression of VEGF and angiopoietin-1 promotes angiogenesis and cardiomyocyte proliferation reduces apoptosis in porcine myocardial infarction (MI) heart. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1018925108
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.